Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech-s Industry Success

Five Star Equities Provides Stock Research on Galena Biopharma and Keryx Biopharmaceuticals

Continue Reading

Biotech Industry Looks to Benefit From FDA-s New “Breakthrough” Designation

Five Star Equities Provides Stock Research on Dendreon and MannKind

Continue Reading

U.S. Banks Collectively Post Second Highest Earnings on Record in 2012 — 17 of 18 Big Banks Pass Stress Tests

Five Star Equities Provides Stock Research on Bank of America and Citigroup

Continue Reading

Results From Latest Stress Tests Show 17 of 18 Big Banks Could Survive Sever Recession

Five Star Equities Provides Stock Research on BB&T and PNC Financial Services

Continue Reading

FDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing

Five Star Equities Provides Stock Research on Medivation and Vertex Pharmaceuticals

Continue Reading

Steadily Improving U.S. Economy Sees U.S. Banks Post Second Highest Earnings on Record in 2012

Five Star Equities Provides Stock Research on SunTrust Banks and U.S. Bancorp

Continue Reading

New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry-s Growth in 2012

Five Star Equities Provides Stock Research on Achillion Pharmaceuticals and ISIS Pharmaceuticals

Continue Reading

U.S. Banking Industry Looking Strong as It Posts Second Highest Earnings on Record in 2012

Five Star Equities Provides Stock Research on Huntington Bancshares and Synovus Financial

Continue Reading

FDIC Reports U.S. Banks Full Year 2012 Earnings Totaled $141.3 Billion — Second Highest on Record

Five Star Equities Provides Stock Research on First Horizon National and KeyCorp

Continue Reading

U.S. Banks Collectively Post Second Highest Earnings on Record in 2012

Five Star Equities Provides Stock Research on Fifth Third Bancorp and Regions Financial

Continue Reading